Early FPI and Centralized ePRO Monitoring Lead to Success for a Phase 2 Osteoarthritis Study
Situation: A Phase 2 Osteoarthritis of the knee study
The Successes:
- Completed enrollment of the trial’s subjects several weeks ahead of schedule because of strong site relationships and experienced CRAs.
- Centrally monitored ePRO compliance after a noticeable decline. CRAs noticed a decline in ePRO compliance, and within a day and with no impact to the budget, Rho experts programmed a heatmap of ePRO compliance for each subject. This allowed the sponsor and CRAs to monitor for and ensure timely compliance of one of the study’s critical endpoints.
- Our Sponsor was incredibly pleased with the successful execution of their trial.